Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $821.00 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $575.26 | 5 | $0 (2023) |
| Novo Nordisk Inc | $120.78 | 1 | $0 (2023) |
| Medtronic Vascular, Inc. | $103.32 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $21.64 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $241.57 | 2 | Gilead Sciences, Inc. ($120.79) |
| 2019 | $342.62 | 3 | Gilead Sciences, Inc. ($239.30) |
| 2018 | $226.35 | 3 | Gilead Sciences, Inc. ($215.17) |
| 2017 | $10.46 | 1 | AstraZeneca Pharmaceuticals LP ($10.46) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.78 | General |
| Category: Obesity | ||||||
| 03/01/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.79 | General |
| 09/26/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.53 | General |
| 04/29/2019 | Medtronic Vascular, Inc. | Endurant (Device) | Food and Beverage | In-kind items and services | $103.32 | General |
| Category: Aortic Stent Grafts | ||||||
| 02/07/2019 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $120.77 | General |
| Category: HIV | ||||||
| 10/01/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/21/2018 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $103.16 | General |
| Category: HBV | ||||||
| 03/13/2018 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $112.01 | General |
| Category: HIV | ||||||
| 03/24/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Michael Vu, D.O
Dr. Michael Vu, D.O is a Internal Medicine healthcare provider based in Tehachapi, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174725006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Vu, D.O has received a total of $821.00 in payments from pharmaceutical and medical device companies, with $241.57 received in 2023. These payments were reported across 9 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($821.00).
Practice Information
- Specialty Internal Medicine
- Location Tehachapi, CA
- Active Since 06/04/2007
- Last Updated 10/14/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174725006
Products in Payments
- Biktarvy (Drug) $232.78
- Wegovy (Drug) $120.78
- Endurant (Device) $103.32
- Vemlidy (Drug) $103.16
- FARXIGA (Drug) $21.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tehachapi
Karandeep Singh, M.d, M.D
Internal Medicine — Payments: $2,038
Dr. Taiga Inoue, Md, Ms, MD, MS
Internal Medicine — Payments: $1,835
Ana Reyna, Md, MD
Internal Medicine — Payments: $93.17
Dr. Mariana Revelo, Md, MD
Internal Medicine
Dr. Terry Warsaw, M.d, M.D
Internal Medicine
Dr. Harold Tate, M.d, M.D
Internal Medicine